All filters
Slidesets
Clinical considerations in switching antiretroviral therapy- David Jilich, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Possible misclassification of HIV transmission between men: results of phylogenetic analysis- Natia Dvali
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Real-life effectiveness of ledipasvir/sofosbuvir regimen and factors associated with retention in care among HIV/HCV co-infected PWID in Ukraine- Tetyana Kyrychenko
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Spontaneous HCV clearance in HCV/HIV coinfected patients from AIDS Center Prague- Viktor Aster
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Epidemiology of HIV in the Baltic countries (Estonia, Latvia, Lithuania)- Saulius Caplinskas
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Critical assessment of the global epidemiology of HCV- Peter Ferenci, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Liver transplantation for HCV and HBV in The Czech Republic- Soña Frankova, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
The EpiTer-2 database- Robert Flisiak, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Case Study: The changing IV drug use problem/pattern and what that means to the epidemic- Mojca Maticic, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Mortality and causes of death among HIV/HCV co-infected persons in the Eastern European country of Georgia- Akaki Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
HCV resistance-associated variants among HCV treatment naïve HIVcoinfected patients in Ukraine. A pilot study- Marta Vasylyev
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Hepatitis B cure strategies: how far are we?- Heiner Wedemeyer, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
New delivery systems and long acting antiretroviral drugs- David Back, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Early results of pre-exposure prophylaxis program in Georgia- Nikoloz Chkhartishvili
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
The Regression of Liver Fibrosis in HCV Cirrhotic Patients Who Registered SVR after DAA Therapy- Anca Leustean
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Insulin-like growth factor and platelet-derived growth factor in liver cells of patients with chronic hepatitis C at different stages of fibrosis- Igor Tikhonov
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
HIV PrEP- Pep Coll, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
The HIV epidemic in CEE countries- Oana Săndulescu, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
How would the epidemic evolve in the future- David van de Vijver
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Long acting HIV drugs for prevention: what are the data?- Pep Coll, MD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
HIV transmission in the migrant population- Dimitrios Paraskevis, PhD
Presented at:
European Meeting on HIV & Hepatitis 2018
Slidesets
Is there a need for HCV resistance testing in routine diagnostics and patient treatment? - Routine HCV genotyping and resistance testing and performance of the Sentosa SQ HCV Genotyping v2.0 assaysing next-generation sequencing- Robert Ehret
Presented at:
European Meeting on HIV & Hepatitis 2018